Medical University of Vienna-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2022

  1. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

    The Lancet Oncology, Vol. 23, Núm. 1, pp. 77-90

2014

  1. Awareness and understanding of cancer immunotherapy in Europe

    Human Vaccines and Immunotherapeutics, Vol. 10, Núm. 7, pp. 1828-1835

  2. Therapeutic vaccines for cancer: An overview of clinical trials

    Nature Reviews Clinical Oncology, Vol. 11, Núm. 9, pp. 509-524